|
CAPRIN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.951200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.439040E-04 |
| Normal-vs-Stage2 |
2.866000E-01 |
| Normal-vs-Stage3 |
5.589600E-01 |
| Normal-vs-Stage4 |
3.272200E-01 |
| Stage1-vs-Stage2 |
3.467000E-01 |
| Stage1-vs-Stage3 |
9.454400E-02 |
| Stage1-vs-Stage4 |
5.684400E-01 |
| Stage2-vs-Stage3 |
6.654800E-01 |
| Stage2-vs-Stage4 |
9.050000E-01 |
| Stage3-vs-Stage4 |
6.367400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.803800E-04 |
| Normal-vs-AfricanAmerican |
2.078500E-02 |
| Normal-vs-Asian |
3.037800E-01 |
| Caucasian-vs-AfricanAmerican |
7.134200E-01 |
| Caucasian-vs-Asian |
9.111800E-01 |
| AfricanAmerican-vs-Asian |
7.910600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5893900000008E-05 |
| Normal-vs-Female |
8.755000E-01 |
| Male-vs-Female |
1.776940E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.085720E-02 |
| Normal-vs-Extreme_Weight |
1.55544999999035E-05 |
| Normal-vs-Obese |
2.892200E-01 |
| Normal-vs-Extreme_Obese |
3.850500E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.227800E-01 |
| Normal_Weight-vs-Obese |
1.961430E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.174400E-01 |
| Extreme_Weight-vs-Obese |
9.619800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.986800E-01 |
| Obese-vs-Extreme_Obese |
1.829570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.048200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.283500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.03949999999509E-05 |
| Normal-vs-Age(81-100Yrs) |
1.994500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.002200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.312290E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.202100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.018400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.616500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.555200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.041120E-04 |
| Normal-VS-Type2 PRCC |
1.491840E-02 |
| Normal-VS-KIRP CIMP |
3.082800E-01 |
| Normal-VS-Unclassified PRCC |
4.107800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.857400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.641400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.086000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.394000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.583600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.376440E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.36239999999288E-05 |
| Normal-vs-N1 |
4.839400E-01 |
| Normal-vs-N2 |
2.461700E-02 |
| N0-vs-N1 |
1.143980E-03 |
| N0-vs-N2 |
9.244600E-01 |
| N1-vs-N2 |
1.688410E-01 |
|
|
